ID   S36A2_HUMAN             Reviewed;         483 AA.
AC   Q495M3; Q495M4; Q495M6; Q6ZWK5; Q7Z6B5;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   15-MAR-2017, entry version 102.
DE   RecName: Full=Proton-coupled amino acid transporter 2;
DE            Short=Proton/amino acid transporter 2;
DE   AltName: Full=Solute carrier family 36 member 2;
DE   AltName: Full=Tramdorin-1;
GN   Name=SLC36A2; Synonyms=PAT2, TRAMD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=12809675; DOI=10.1016/S0888-7543(03)00099-5;
RA   Boll M., Foltz M., Rubio-Aliaga I., Daniel H.;
RT   "A cluster of proton/amino acid transporter genes in the human and
RT   mouse genomes.";
RL   Genomics 82:47-56(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=15058382; DOI=10.1007/s00335-003-2319-3;
RA   Bermingham J.R. Jr., Pennington J.;
RT   "Organization and expression of the SLC36 cluster of amino acid
RT   transporter genes.";
RL   Mamm. Genome 15:114-125(2004).
RN   [6]
RP   FUNCTION, TISSUE SPECIFICITY, VARIANT IG VAL-87, VARIANT HG VAL-87,
RP   AND CHARACTERIZATION OF VARIANT HG VAL-87.
RX   PubMed=19033659; DOI=10.1172/JCI36625;
RA   Broer S., Bailey C.G., Kowalczuk S., Ng C., Vanslambrouck J.M.,
RA   Rodgers H., Auray-Blais C., Cavanaugh J.A., Broer A., Rasko J.E.;
RT   "Iminoglycinuria and hyperglycinuria are discrete human phenotypes
RT   resulting from complex mutations in proline and glycine
RT   transporters.";
RL   J. Clin. Invest. 118:3881-3892(2008).
CC   -!- FUNCTION: Involved in a pH-dependent electrogenic neuronal
CC       transport and sequestration of small amino acids. Transports
CC       glycine and proline. Inhibited by sarcosine (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:19033659}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q495M3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q495M3-2; Sequence=VSP_032372;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q495M3-3; Sequence=VSP_032371, VSP_032373;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in kidney and muscle.
CC       Expressed in the S1 segment of the proximal tubule close to the
CC       glomerulus. {ECO:0000269|PubMed:15058382,
CC       ECO:0000269|PubMed:19033659}.
CC   -!- DISEASE: Hyperglycinuria (HG) [MIM:138500]: A condition
CC       characterized by excess of glycine in the urine. In some cases it
CC       is associated with renal colic and renal oxalate stones.
CC       {ECO:0000269|PubMed:19033659}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Iminoglycinuria (IG) [MIM:242600]: A disorder of renal
CC       tubular reabsorption of glycine and imino acids (proline and
CC       hydroxyproline), marked by excessive levels of all three
CC       substances in the urine. {ECO:0000269|PubMed:19033659}. Note=The
CC       disease is caused by mutations affecting distinct genetic loci,
CC       including the gene represented in this entry. Mutations in SLC36A2
CC       that retain residual transport activity result in the IG phenotype
CC       only when combined with haploinsufficiency of the imino acid
CC       transporter SLC6A20 or deficiency of the neutral amino acid
CC       transporter SLC6A19. Additional polymorphisms and mutations in
CC       SLC6A18 can contribute to iminoglycinuria in some families.
CC   -!- SIMILARITY: Belongs to the amino acid/polyamine transporter 2
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY162214; AAO11788.1; -; mRNA.
DR   EMBL; AK122630; BAC85496.1; -; mRNA.
DR   EMBL; CH471062; EAW61678.1; -; Genomic_DNA.
DR   EMBL; BC101100; AAI01101.1; -; mRNA.
DR   EMBL; BC101101; AAI01102.1; -; mRNA.
DR   EMBL; BC101102; AAI01103.1; -; mRNA.
DR   EMBL; BC101103; AAI01104.1; -; mRNA.
DR   CCDS; CCDS4315.1; -. [Q495M3-1]
DR   RefSeq; NP_861441.2; NM_181776.2. [Q495M3-1]
DR   RefSeq; XP_016864573.1; XM_017009084.1. [Q495M3-2]
DR   UniGene; Hs.483877; -.
DR   ProteinModelPortal; Q495M3; -.
DR   IntAct; Q495M3; 1.
DR   STRING; 9606.ENSP00000334223; -.
DR   DrugBank; DB00260; Cycloserine.
DR   GuidetoPHARMACOLOGY; 1162; -.
DR   TCDB; 2.A.18.8.6; the amino acid/auxin permease (aaap) family.
DR   iPTMnet; Q495M3; -.
DR   PhosphoSitePlus; Q495M3; -.
DR   BioMuta; SLC36A2; -.
DR   DMDM; 121943282; -.
DR   PaxDb; Q495M3; -.
DR   PeptideAtlas; Q495M3; -.
DR   PRIDE; Q495M3; -.
DR   Ensembl; ENST00000335244; ENSP00000334223; ENSG00000186335. [Q495M3-1]
DR   GeneID; 153201; -.
DR   KEGG; hsa:153201; -.
DR   UCSC; uc003lty.3; human. [Q495M3-1]
DR   CTD; 153201; -.
DR   DisGeNET; 153201; -.
DR   GeneCards; SLC36A2; -.
DR   HGNC; HGNC:18762; SLC36A2.
DR   HPA; HPA044002; -.
DR   HPA; HPA062229; -.
DR   MalaCards; SLC36A2; -.
DR   MIM; 138500; phenotype.
DR   MIM; 242600; phenotype.
DR   MIM; 608331; gene.
DR   neXtProt; NX_Q495M3; -.
DR   OpenTargets; ENSG00000186335; -.
DR   Orphanet; 42062; Iminoglycinuria.
DR   PharmGKB; PA134899820; -.
DR   eggNOG; KOG1304; Eukaryota.
DR   eggNOG; COG0814; LUCA.
DR   GeneTree; ENSGT00390000011245; -.
DR   HOGENOM; HOG000006823; -.
DR   HOVERGEN; HBG057183; -.
DR   InParanoid; Q495M3; -.
DR   KO; K14209; -.
DR   OMA; CHYNETV; -.
DR   OrthoDB; EOG091G079T; -.
DR   PhylomeDB; Q495M3; -.
DR   TreeFam; TF314873; -.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   Reactome; R-HSA-428559; Proton-coupled neutral amino acid transporters.
DR   ChiTaRS; SLC36A2; human.
DR   GeneWiki; SLC36A2; -.
DR   GenomeRNAi; 153201; -.
DR   PRO; PR:Q495M3; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000186335; -.
DR   CleanEx; HS_SLC36A2; -.
DR   ExpressionAtlas; Q495M3; baseline and differential.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005774; C:vacuolar membrane; IBA:GO_Central.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015187; F:glycine transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0015078; F:hydrogen ion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005280; F:hydrogen:amino acid symporter activity; IBA:GO_Central.
DR   GO; GO:0015180; F:L-alanine transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015193; F:L-proline transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0035524; P:proline transmembrane transport; IMP:UniProtKB.
DR   InterPro; IPR013057; AA_transpt_TM.
DR   Pfam; PF01490; Aa_trans; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Amino-acid transport; Cell membrane;
KW   Complete proteome; Cytoplasm; Disease mutation; Membrane;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    483       Proton-coupled amino acid transporter 2.
FT                                /FTId=PRO_0000324819.
FT   TOPO_DOM      1     58       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     59     79       Helical. {ECO:0000255}.
FT   TOPO_DOM     80     81       Extracellular. {ECO:0000255}.
FT   TRANSMEM     82    102       Helical. {ECO:0000255}.
FT   TOPO_DOM    103    148       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    149    169       Helical. {ECO:0000255}.
FT   TOPO_DOM    170    197       Extracellular. {ECO:0000255}.
FT   TRANSMEM    198    218       Helical. {ECO:0000255}.
FT   TOPO_DOM    219    222       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    223    243       Helical. {ECO:0000255}.
FT   TOPO_DOM    244    264       Extracellular. {ECO:0000255}.
FT   TRANSMEM    265    285       Helical. {ECO:0000255}.
FT   TOPO_DOM    286    296       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    297    317       Helical. {ECO:0000255}.
FT   TOPO_DOM    318    349       Extracellular. {ECO:0000255}.
FT   TRANSMEM    350    370       Helical. {ECO:0000255}.
FT   TOPO_DOM    371    379       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    380    400       Helical. {ECO:0000255}.
FT   TOPO_DOM    401    404       Extracellular. {ECO:0000255}.
FT   TRANSMEM    405    425       Helical. {ECO:0000255}.
FT   TOPO_DOM    426    437       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    438    458       Helical. {ECO:0000255}.
FT   TOPO_DOM    459    483       Extracellular. {ECO:0000255}.
FT   VAR_SEQ       1    276       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032371.
FT   VAR_SEQ       1    198       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032372.
FT   VAR_SEQ     277    281       ESIGV -> MNDTA (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032373.
FT   VARIANT      87     87       G -> V (in HG and IG; partially
FT                                inactivating mutation; results in a 3-
FT                                fold increase of Km value for proline and
FT                                a 5-fold increase of Km for glycine;
FT                                dbSNP:rs77010315).
FT                                {ECO:0000269|PubMed:19033659}.
FT                                /FTId=VAR_064795.
FT   VARIANT     445    445       A -> V (in dbSNP:rs10042608).
FT                                /FTId=VAR_039887.
FT   CONFLICT    156    156       I -> N (in Ref. 1; AAO11788).
FT                                {ECO:0000305}.
FT   CONFLICT    408    408       S -> P (in Ref. 1; AAO11788).
FT                                {ECO:0000305}.
FT   CONFLICT    410    410       V -> M (in Ref. 2; BAC85496).
FT                                {ECO:0000305}.
FT   CONFLICT    429    429       T -> P (in Ref. 2; BAC85496).
FT                                {ECO:0000305}.
SQ   SEQUENCE   483 AA;  53216 MW;  E283B8C6F0C63666 CRC64;
     MSVTKSTEGP QGAVAIKLDL MSPPESAKKL ENKDSTFLDE SPSESAGLKK TKGITVFQAL
     IHLVKGNMGT GILGLPLAVK NAGILMGPLS LLVMGFIACH CMHILVKCAQ RFCKRLNKPF
     MDYGDTVMHG LEANPNAWLQ NHAHWGRHIV SFFLIITQLG FCCVYIVFLA DNLKQVVEAV
     NSTTNNCYSN ETVILTPTMD SRLYMLSFLP FLVLLVLIRN LRILTIFSML ANISMLVSLV
     IIIQYITQEI PDPSRLPLVA SWKTYPLFFG TAIFSFESIG VVLPLENKMK NARHFPAILS
     LGMSIVTSLY IGMAALGYLR FGDDIKASIS LNLPNCWLYQ SVKLLYIAGI LCTYALQFYV
     PAEIIIPFAI SRVSTRWALP LDLSIRLVMV CLTCLLAILI PRLDLVISLV GSVSGTALAL
     IIPPLLEVTT FYSEGMSPLT IFKDALISIL GFVGFVVGTY QALDELLKSE DSHPFSNSTT
     FVR
//
